1. Home
  2. KMB vs IQV Comparison

KMB vs IQV Comparison

Compare KMB & IQV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kimberly-Clark Corporation

KMB

Kimberly-Clark Corporation

HOLD

Current Price

$100.64

Market Cap

35.5B

ML Signal

HOLD

Logo IQVIA Holdings Inc.

IQV

IQVIA Holdings Inc.

HOLD

Current Price

$220.01

Market Cap

36.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KMB
IQV
Founded
1910
1982
Country
United States
United States
Employees
N/A
N/A
Industry
Containers/Packaging
Biotechnology: Commercial Physical & Biological Resarch
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
35.5B
36.4B
IPO Year
N/A
2013

Fundamental Metrics

Financial Performance
Metric
KMB
IQV
Price
$100.64
$220.01
Analyst Decision
Hold
Buy
Analyst Count
12
15
Target Price
$128.08
$236.93
AVG Volume (30 Days)
6.1M
1.5M
Earning Date
01-27-2026
02-05-2026
Dividend Yield
5.01%
N/A
EPS Growth
N/A
N/A
EPS
5.91
7.30
Revenue
$19,724,000,000.00
$15,904,000,000.00
Revenue This Year
N/A
$6.14
Revenue Next Year
$2.10
$5.35
P/E Ratio
$17.01
$30.22
Revenue Growth
11.62
3.85
52 Week Low
$99.22
$134.65
52 Week High
$150.45
$234.30

Technical Indicators

Market Signals
Indicator
KMB
IQV
Relative Strength Index (RSI) 32.90 47.58
Support Level $101.92 $220.12
Resistance Level $103.80 $225.80
Average True Range (ATR) 1.59 5.19
MACD 0.02 -1.06
Stochastic Oscillator 4.90 35.74

Price Performance

Historical Comparison
KMB
IQV

About KMB Kimberly-Clark Corporation

With more than half of its sales from personal care and another third from consumer tissue products, Kimberly-Clark is a leading manufacturer in the tissue and hygiene realm. Its brand mix includes Huggies, PullUps, Kotex, Depend, Kleenex, and Cottonelle. The firm also operates in the professional segment, partnering with businesses to provide safety and sanitary offerings for the workplace. Kimberly-Clark generates just over half its sales in North America and more than 10% in Europe, with the rest primarily concentrated in Asia and Latin America. It intends to add Kenvue's consumer health portfolio to its mix in the second half of calendar year 2026.

About IQV IQVIA Holdings Inc.

Iqvia is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The research and development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.

Share on Social Networks: